Everolimus

Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants[8] and as a targeted therapy in the treatment of renal cell cancer and other tumours.[9] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).[10] It is marketed by Novartis under the trade names Zortress (US)... [wikipedia]